anmelden
SPI
20.040,99
PKT
+86,63
PKT
+0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 10.02.12 | UBS sector perform | RBC Capital Markets | |
| 10.02.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 09.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 09.02.12 | UBS hold | Commerzbank Corp. & Markets | |
| 09.02.12 | UBS outperform | Macquarie Research | |
| 09.02.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 09.02.12 | Swatch (I) kaufen | Focus Money | |
| 09.02.12 | UBS sell | Deutsche Bank AG | |
| 09.02.12 | UBS outperform | RBC Capital Markets | |
| 08.02.12 | Holcim hold | Deutsche Bank AG | |
| 08.02.12 | Holcim hold | Deutsche Bank AG | |
| 08.02.12 | Zurich Insurance buy | Deutsche Bank AG | |
| 08.02.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 08.02.12 | Swatch (I) buy | Société Générale Group S.A. (SG) | |
| 08.02.12 | UBS buy | Nomura | |
| 08.02.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | Swatch (I) buy | Sarasin Research | |
| 08.02.12 | UBS overweight | Morgan Stanley | |
| 08.02.12 | Swatch (I) buy | Nomura | |
| 08.02.12 | UBS verkaufen | Independent Research GmbH | |
| 07.02.12 | UBS neutral | WestLB AG | |
| 07.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 07.02.12 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 07.02.12 | UBS neutral | Sarasin Research | |
| 07.02.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 07.02.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 07.02.12 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 07.02.12 | Swatch (I) kaufen | Sarasin Research | |
| 07.02.12 | Julius Bär buy | Sarasin Research | |
| 07.02.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 06.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 06.02.12 | ABB (Asea Brown Boveri) neutral | UBS AG | |
| 06.02.12 | BB Biotech kaufen | Euro am Sonntag | |
| 06.02.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 03.02.12 | Roche outperform | Exane-BNP Paribas SA | |
| 03.02.12 | Holcim hold | Deutsche Bank AG | |
| 03.02.12 | Roche overweight | Barclays Capital | |
| 03.02.12 | Givaudan neutral | UBS AG | |
| 03.02.12 | Bucher Industries neutral | UBS AG |